These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
Virginia
|
|
54-1497771
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
1100 Boulders Parkway
Richmond, Virginia
|
|
23225
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
|
Large accelerated filer
|
|
x
|
Accelerated filer
|
|
¨
|
|
|
|
|
|
||
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
|
¨
|
|
Item 1.
|
Financial Statements.
|
|
|
September 30,
|
|
December 31,
|
||||
|
|
2016
|
|
2015
|
||||
|
Assets
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
28,356
|
|
|
$
|
44,156
|
|
|
Accounts and other receivables, net of allowance for doubtful accounts and sales returns of $3,206 in 2016 and $3,746 in 2015
|
104,394
|
|
|
94,217
|
|
||
|
Income taxes recoverable
|
4,622
|
|
|
360
|
|
||
|
Inventories
|
73,273
|
|
|
65,325
|
|
||
|
Prepaid expenses and other
|
6,351
|
|
|
6,946
|
|
||
|
Total current assets
|
216,996
|
|
|
211,004
|
|
||
|
Property, plant and equipment, at cost
|
795,087
|
|
|
754,678
|
|
||
|
Less accumulated depreciation
|
(538,308
|
)
|
|
(523,363
|
)
|
||
|
Net property, plant and equipment
|
256,779
|
|
|
231,315
|
|
||
|
Goodwill and other intangibles, net
|
152,505
|
|
|
153,072
|
|
||
|
Other assets and deferred charges
|
29,490
|
|
|
27,869
|
|
||
|
Total assets
|
$
|
655,770
|
|
|
$
|
623,260
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
88,073
|
|
|
$
|
84,148
|
|
|
Accrued expenses
|
36,871
|
|
|
33,653
|
|
||
|
Total current liabilities
|
124,944
|
|
|
117,801
|
|
||
|
Long-term debt
|
91,750
|
|
|
104,000
|
|
||
|
Deferred income taxes
|
19,813
|
|
|
18,656
|
|
||
|
Other noncurrent liabilities
|
101,345
|
|
|
110,055
|
|
||
|
Total liabilities
|
337,852
|
|
|
350,512
|
|
||
|
Commitments and contingencies (Notes 1 and 12)
|
|
|
|
||||
|
Shareholders’ equity:
|
|
|
|
||||
|
Common stock, no par value (issued and outstanding - 32,921,549 at September 30, 2016 and 32,682,162 at December 31, 2015)
|
32,268
|
|
|
29,467
|
|
||
|
Common stock held in trust for savings restoration plan (69,207 shares at September 30, 2016 and 67,726 shares at December 31, 2015)
|
(1,490
|
)
|
|
(1,467
|
)
|
||
|
Accumulated other comprehensive income (loss):
|
|
|
|
||||
|
Foreign currency translation adjustment
|
(89,878
|
)
|
|
(112,807
|
)
|
||
|
Gain/(loss) on derivative financial instruments
|
590
|
|
|
(373
|
)
|
||
|
Pension and other post-retirement benefit adjustments
|
(88,966
|
)
|
|
(95,539
|
)
|
||
|
Retained earnings
|
465,394
|
|
|
453,467
|
|
||
|
Total shareholders’ equity
|
317,918
|
|
|
272,748
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
655,770
|
|
|
$
|
623,260
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Revenues and other items:
|
|
|
|
|
|
|
|
||||||||
|
Sales
|
$
|
207,702
|
|
|
$
|
223,772
|
|
|
$
|
623,569
|
|
|
$
|
679,188
|
|
|
Other income (expense), net
|
388
|
|
|
147
|
|
|
1,481
|
|
|
379
|
|
||||
|
|
208,090
|
|
|
223,919
|
|
|
625,050
|
|
|
679,567
|
|
||||
|
Costs and expenses:
|
|
|
|
|
|
|
|
||||||||
|
Cost of goods sold
|
166,622
|
|
|
182,442
|
|
|
499,504
|
|
|
555,627
|
|
||||
|
Freight
|
7,153
|
|
|
7,862
|
|
|
21,221
|
|
|
22,930
|
|
||||
|
Selling, general and administrative
|
17,383
|
|
|
14,709
|
|
|
57,027
|
|
|
53,680
|
|
||||
|
Research and development
|
4,519
|
|
|
3,774
|
|
|
14,458
|
|
|
11,926
|
|
||||
|
Amortization of intangibles
|
1,019
|
|
|
990
|
|
|
2,965
|
|
|
3,113
|
|
||||
|
Interest expense
|
886
|
|
|
901
|
|
|
2,918
|
|
|
2,679
|
|
||||
|
Asset impairments and costs associated with exit and disposal activities, net of adjustments
|
1,129
|
|
|
2,117
|
|
|
2,355
|
|
|
2,342
|
|
||||
|
Goodwill impairment charge
|
—
|
|
|
44,465
|
|
|
—
|
|
|
44,465
|
|
||||
|
Total
|
198,711
|
|
|
257,260
|
|
|
600,448
|
|
|
696,762
|
|
||||
|
Income (loss) before income taxes
|
9,379
|
|
|
(33,341
|
)
|
|
24,602
|
|
|
(17,195
|
)
|
||||
|
Income taxes (benefit)
|
(2,669
|
)
|
|
3,382
|
|
|
1,864
|
|
|
9,064
|
|
||||
|
Net income (loss)
|
$
|
12,048
|
|
|
$
|
(36,723
|
)
|
|
$
|
22,738
|
|
|
$
|
(26,259
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings (loss)
per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.37
|
|
|
$
|
(1.13
|
)
|
|
$
|
0.69
|
|
|
$
|
(0.81
|
)
|
|
Diluted
|
$
|
0.37
|
|
|
$
|
(1.13
|
)
|
|
$
|
0.69
|
|
|
$
|
(0.81
|
)
|
|
Shares used to compute earnings (loss) per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
32,818
|
|
|
32,605
|
|
|
32,730
|
|
|
32,566
|
|
||||
|
Diluted
|
32,828
|
|
|
32,605
|
|
|
32,733
|
|
|
32,566
|
|
||||
|
Dividends per share
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
$
|
0.33
|
|
|
$
|
0.31
|
|
|
|
Three Months Ended September 30,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Net income (loss)
|
$
|
12,048
|
|
|
$
|
(36,723
|
)
|
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Foreign currency translation adjustment (net of tax benefit of $77 in 2016 and tax benefit of $122 in 2015)
|
(719
|
)
|
|
(35,526
|
)
|
||
|
Derivative financial instruments adjustment (net of tax benefit of $31 in 2016 and tax benefit of $92 in 2015)
|
(54
|
)
|
|
(155
|
)
|
||
|
Amortization of prior service costs and net gains or losses (net of tax of $1,120 in 2016 and tax of $1,478 in 2015)
|
1,966
|
|
|
2,550
|
|
||
|
Other comprehensive income (loss)
|
1,193
|
|
|
(33,131
|
)
|
||
|
Comprehensive income (loss)
|
$
|
13,241
|
|
|
$
|
(69,854
|
)
|
|
|
|
|
|
||||
|
|
Nine Months Ended September 30,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Net income (loss)
|
$
|
22,738
|
|
|
$
|
(26,259
|
)
|
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Foreign currency translation adjustment (net of tax benefit of $307 in 2016 and tax benefit of $1,506 in 2015)
|
22,929
|
|
|
(64,622
|
)
|
||
|
Derivative financial instruments adjustment (net of tax of $567 in 2016 and tax benefit of $1,082 in 2015)
|
963
|
|
|
(1,796
|
)
|
||
|
Amortization of prior service costs and net gains or losses (net of tax of $3,186 in 2016 and tax of $4,402 in 2015)
|
6,573
|
|
|
7,595
|
|
||
|
Other comprehensive income (loss)
|
30,465
|
|
|
(58,823
|
)
|
||
|
Comprehensive income (loss)
|
$
|
53,203
|
|
|
$
|
(85,082
|
)
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income (loss)
|
$
|
22,738
|
|
|
$
|
(26,259
|
)
|
|
Adjustments for noncash items:
|
|
|
|
||||
|
Depreciation
|
21,004
|
|
|
23,932
|
|
||
|
Amortization of intangibles
|
2,965
|
|
|
3,113
|
|
||
|
Goodwill impairment charge
|
—
|
|
|
44,465
|
|
||
|
Deferred income taxes
|
(5,122
|
)
|
|
(7,526
|
)
|
||
|
Accrued pension and post-retirement benefits
|
8,168
|
|
|
9,358
|
|
||
|
Loss on investment accounted for under the fair value method
|
200
|
|
|
—
|
|
||
|
Loss on asset impairments and divestitures
|
412
|
|
|
319
|
|
||
|
Net gain on disposal of assets
|
—
|
|
|
(11
|
)
|
||
|
Gain from insurance recoveries
|
(1,634
|
)
|
|
—
|
|
||
|
Changes in assets and liabilities, net of effects of acquisitions and divestitures:
|
|
|
|
||||
|
Accounts and other receivables
|
(4,919
|
)
|
|
(4,725
|
)
|
||
|
Inventories
|
(5,188
|
)
|
|
1,205
|
|
||
|
Income taxes recoverable/payable
|
(4,095
|
)
|
|
184
|
|
||
|
Prepaid expenses and other
|
(514
|
)
|
|
(1,141
|
)
|
||
|
Accounts payable and accrued expenses
|
4,857
|
|
|
(9,028
|
)
|
||
|
Other, net
|
(4,450
|
)
|
|
(544
|
)
|
||
|
Net cash provided by operating activities
|
34,422
|
|
|
33,342
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Capital expenditures
|
(30,912
|
)
|
|
(23,382
|
)
|
||
|
Proceeds from the sale of assets and other
|
1,399
|
|
|
949
|
|
||
|
Net cash used in investing activities
|
(29,513
|
)
|
|
(22,433
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Borrowings
|
61,000
|
|
|
88,000
|
|
||
|
Debt principal payments
|
(73,250
|
)
|
|
(91,250
|
)
|
||
|
Dividends paid
|
(10,834
|
)
|
|
(10,130
|
)
|
||
|
Debt financing costs
|
(2,509
|
)
|
|
(78
|
)
|
||
|
Proceeds from exercise of stock options and other
|
2,073
|
|
|
2,794
|
|
||
|
Net cash used in financing activities
|
(23,520
|
)
|
|
(10,664
|
)
|
||
|
Effect of exchange rate changes on cash
|
2,811
|
|
|
(3,692
|
)
|
||
|
Decrease in cash and cash equivalents
|
(15,800
|
)
|
|
(3,447
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
44,156
|
|
|
50,056
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
28,356
|
|
|
$
|
46,609
|
|
|
|
|
|
Accumulated Other
Comprehensive Income (Loss)
|
|
|
||||||||||||||||||||||
|
|
Common
Stock
|
|
Retained
Earnings
|
|
Trust for
Savings
Restoration
Plan
|
|
Foreign
Currency
Translation
|
|
Gain
(Loss) on
Derivative
Financial
Instruments
|
|
Pension &
Other
Post-retirement
Benefit
Adjust.
|
|
Total
Shareholders’
Equity
|
||||||||||||||
|
Balance at January 1, 2016
|
$
|
29,467
|
|
|
$
|
453,467
|
|
|
$
|
(1,467
|
)
|
|
$
|
(112,807
|
)
|
|
$
|
(373
|
)
|
|
$
|
(95,539
|
)
|
|
$
|
272,748
|
|
|
Net income
|
—
|
|
|
22,738
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,738
|
|
|||||||
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Foreign currency translation adjustment (net of tax benefit of $307)
|
—
|
|
|
—
|
|
|
—
|
|
|
22,929
|
|
|
—
|
|
|
—
|
|
|
22,929
|
|
|||||||
|
Derivative financial instruments adjustment (net of tax of $567)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
963
|
|
|
—
|
|
|
963
|
|
|||||||
|
Amortization of prior service costs and net gains or losses (net of tax of $3,186)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,573
|
|
|
6,573
|
|
|||||||
|
Cash dividends declared ($0.33 per share)
|
—
|
|
|
(10,834
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,834
|
)
|
|||||||
|
Stock-based compensation expense
|
1,308
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,308
|
|
|||||||
|
Issued upon exercise of stock options & other
|
1,493
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,493
|
|
|||||||
|
Tredegar common stock purchased by trust for savings restoration plan
|
—
|
|
|
23
|
|
|
(23
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Balance at September 30, 2016
|
$
|
32,268
|
|
|
$
|
465,394
|
|
|
$
|
(1,490
|
)
|
|
$
|
(89,878
|
)
|
|
$
|
590
|
|
|
$
|
(88,966
|
)
|
|
$
|
317,918
|
|
|
1.
|
In the opinion of management, the accompanying consolidated financial statements of Tredegar Corporation and its subsidiaries (“Tredegar,” “the Company,” “we,” “us” or “our”) contain all adjustments necessary to state fairly, in all material respects, Tredegar’s consolidated financial position as of
September 30, 2016
, the consolidated results of operations for the
three and nine
months ended
September 30, 2016
and
2015
, the consolidated cash flows for the
nine months
ended
September 30, 2016
and
2015
, and the consolidated changes in shareholders’ equity for the
nine months
ended
September 30, 2016
. All such adjustments, unless otherwise detailed in the notes to the consolidated interim financial statements, are deemed to be of a normal, recurring nature. The financial position data as of
December 31, 2015
that is included herein was derived from the audited consolidated financial statements provided in the Company’s Annual Report on Form 10-K/A for the year ended
December 31, 2015
(“
2015
Form 10-K”) but does not include all disclosures required by United States generally accepted accounting principles (“GAAP”). These financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s
2015
Form 10-K. The results of operations for the
three and nine
months ended
September 30, 2016
, are not necessarily indicative of the results to be expected for the full year.
|
|
2.
|
Plant shutdowns, asset impairments, restructurings and other items are shown in the net sales and operating profit by segment table in Note 9 and are also included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the consolidated statements of income, unless otherwise noted below.
|
|
•
|
Net pretax income of
$1.7 million
related to the explosion that occurred in the second quarter of 2016 at Bonnell’s aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain of
$1.9 million
for a portion of the insurance recoveries approved by the insurer to begin the replacement of capital equipment, offset by the impairment of equipment damaged by the explosion of
$0.3 million
(net amount included in “Other income (expense), net” in the consolidated statements of income), and the reversal of an accrual for costs related to the explosion of
$50,000
(included in “Selling, general and administrative expenses” in the consolidated statements of income).
|
|
•
|
Pretax charges of
$1.1 million
associated with the consolidation of domestic PE Films’ manufacturing facilities, which consists of severance and other employee-related costs of
$0.3 million
, asset impairments of
$0.1 million
, accelerated depreciation of
$0.1 million
(included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of
$0.6 million
(
$0.4 million
included in “Cost of goods sold” in the consolidated statements of income);
|
|
•
|
Pretax charges of
$0.3 million
for severance and other employee-related costs associated with restructurings in PE Films (
$0.1 million
) and Corporate (
$0.2 million
) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment); and
|
|
•
|
Pretax charges of
$0.3 million
associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana.
|
|
•
|
Net pretax income of
$1.1 million
related to the explosion that occurred in the second quarter of 2016 at Bonnell’s aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain of
$1.9 million
for a portion of the insurance recoveries approved by the insurer to begin the replacement of capital equipment, offset by the impairment of equipment damaged by the explosion of
$0.3 million
(net amount included in “Other income (expense), net” in the consolidated statements of income) and other costs related to the explosion not recoverable from insurance of
$0.5 million
(included in “Selling, general and administrative expenses” in the consolidated statements of income).
|
|
•
|
Pretax charges of
$3.6 million
associated with the consolidation of domestic PE Films’ manufacturing facilities, which consists of severance and other employee-related costs of
$0.9 million
, asset impairments of
$0.4 million
, accelerated depreciation of
$0.4 million
(included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of
$1.9 million
(
$1.4 million
is included in “Cost of goods sold” in the consolidated statements of income);
|
|
•
|
Pretax charges of
$0.4 million
associated with a non-recurring business development project (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
|
|
•
|
Pretax charges of
$0.3 million
for severance and other employee-related costs associated with restructurings in PE Films (
$0.1 million
) and Corporate (
$0.2 million
) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment); and
|
|
•
|
Pretax charges of
$0.3 million
associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana.
|
|
•
|
Pretax charges of
$1.2 million
associated with the consolidation of domestic PE Films’ manufacturing facilities, which consists of severance and other employee-related costs of
$0.3 million
, asset impairments of
$0.3 million
, accelerated depreciation of
$0.2 million
(included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of
$0.3 million
(
$46,000
is included in “Cost of goods sold” in the consolidated statements of income);
|
|
•
|
Pretax charges of
$0.9 million
for severance and other employee-related costs associated with restructurings in PE Films (
$0.9 million
), Aluminum Extrusions (
$35,000
) and Corporate (
$26,000
) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment); and
|
|
•
|
Pretax charges of
$0.3 million
associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana.
|
|
•
|
Pretax charges of
$3.9 million
(included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment) for severance and other employee-related costs associated with the resignation of the Company’s former chief executive and chief financial officers;
|
|
•
|
Pretax charges of
$1.2 million
associated with the consolidation of domestic PE Films’ manufacturing facilities, which consists of severance and other employee-related costs of
$0.3 million
, asset impairments of
$0.3 million
, accelerated depreciation of
$0.2 million
(included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of
$0.3 million
(
$46,000
is included in “Cost of goods sold” in the consolidated statements of income);
|
|
•
|
Pretax charge of
$1.1 million
for severance and other employee-related costs associated with restructurings in PE Films (
$0.9 million
), Flexible Packaging Films (
$0.2 million
), Aluminum Extrusions (
$35,000
) and Corporate (
$26,000
) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment); and
|
|
•
|
Pretax charges of
$0.3 million
associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana.
|
|
(In Thousands)
|
Severance
|
|
Asset Impairments
|
|
Other (a)
|
|
Total
|
||||||||
|
Balance at January 1, 2016
|
$
|
1,462
|
|
|
$
|
—
|
|
|
$
|
405
|
|
|
$
|
1,867
|
|
|
Changes in 2016:
|
|
|
|
|
|
|
|
||||||||
|
Charges
|
1,216
|
|
|
412
|
|
|
727
|
|
|
2,355
|
|
||||
|
Cash spent
|
(833
|
)
|
|
—
|
|
|
(593
|
)
|
|
(1,426
|
)
|
||||
|
Charges against assets
|
—
|
|
|
(412
|
)
|
|
—
|
|
|
(412
|
)
|
||||
|
Balance at September 30, 2016
|
$
|
1,845
|
|
|
$
|
—
|
|
|
$
|
539
|
|
|
$
|
2,384
|
|
|
(a) Other includes other facility consolidation-related costs associated with the consolidation of North American PE Films manufacturing facilities and other shutdown-related costs associated with the shutdown of the Company’s aluminum extrusions manufacturing facility in Kentland, Indiana.
|
|||||||||||||||
|
•
|
Cash outlays associated with previously discussed exit and disposal expenses of approximately
$5 million
, including additional operating expenses of approximately
$1 million
associated with customer product qualifications on upgraded and transferred production lines;
|
|
•
|
Capital expenditures associated with equipment upgrades at other PE Films manufacturing facilities in the U.S. of approximately
$11 million
; and
|
|
•
|
Cash incentives of approximately
$1 million
in connection with meeting safety and quality standards while production ramps down at the Lake Zurich manufacturing facility.
|
|
3.
|
The components of inventories are as follows:
|
|
|
|
September 30,
|
|
December 31,
|
||||
|
(In Thousands)
|
2016
|
|
2015
|
|||||
|
Finished goods
|
$
|
17,255
|
|
|
$
|
13,935
|
|
|
|
Work-in-process
|
10,736
|
|
|
9,249
|
|
|||
|
Raw materials
|
26,553
|
|
|
22,149
|
|
|||
|
Stores, supplies and other
|
18,729
|
|
|
19,992
|
|
|||
|
Total
|
$
|
73,273
|
|
|
$
|
65,325
|
|
|
|
4.
|
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 30,
|
|
September 30,
|
||||||||
|
(In Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
|
Weighted average shares outstanding used to compute basic earnings per share
|
32,818
|
|
|
32,605
|
|
|
32,730
|
|
|
32,566
|
|
|
Incremental dilutive shares attributable to stock options and restricted stock
|
10
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
Shares used to compute diluted earnings per share
|
32,828
|
|
|
32,605
|
|
|
32,733
|
|
|
32,566
|
|
|
5.
|
The following table summarizes the after-tax changes in accumulated other comprehensive income (loss) for the
nine months ended
September 30, 2016
:
|
|
(In Thousands)
|
Foreign
currency
translation
adjustment
|
|
Gain (loss) on
derivative
financial
instruments
|
|
Pension and
other
post-retirement
benefit
adjustments
|
|
Total
|
||||||||
|
Beginning balance, January 1, 2016
|
$
|
(112,807
|
)
|
|
$
|
(373
|
)
|
|
$
|
(95,539
|
)
|
|
$
|
(208,719
|
)
|
|
Other comprehensive income (loss) before reclassifications
|
22,929
|
|
|
(60
|
)
|
|
—
|
|
|
22,869
|
|
||||
|
Amounts reclassified from accumulated other comprehensive income (loss)
|
—
|
|
|
1,023
|
|
|
6,573
|
|
|
7,596
|
|
||||
|
Net other comprehensive income (loss) - current period
|
22,929
|
|
|
963
|
|
|
6,573
|
|
|
30,465
|
|
||||
|
Ending balance, September 30, 2016
|
$
|
(89,878
|
)
|
|
$
|
590
|
|
|
$
|
(88,966
|
)
|
|
$
|
(178,254
|
)
|
|
(In Thousands)
|
Foreign
currency translation adjustment |
|
Gain (loss) on
derivative financial instruments |
|
Pension and
other post-retirement benefit adjustments |
|
Total
|
||||||||
|
Beginning balance, January 1, 2015
|
$
|
(47,270
|
)
|
|
$
|
656
|
|
|
$
|
(103,581
|
)
|
|
$
|
(150,195
|
)
|
|
Other comprehensive income (loss) before reclassifications
|
(64,622
|
)
|
|
(2,930
|
)
|
|
—
|
|
|
(67,552
|
)
|
||||
|
Amounts reclassified from accumulated other comprehensive income (loss)
|
—
|
|
|
1,134
|
|
|
7,595
|
|
|
8,729
|
|
||||
|
Net other comprehensive income (loss) - current period
|
(64,622
|
)
|
|
(1,796
|
)
|
|
7,595
|
|
|
(58,823
|
)
|
||||
|
Ending balance, September 30, 2015
|
$
|
(111,892
|
)
|
|
$
|
(1,140
|
)
|
|
$
|
(95,986
|
)
|
|
$
|
(209,018
|
)
|
|
(In Thousands)
|
Amount
reclassified from other comprehensive income (loss) |
|
Location of gain
(loss) reclassified from accumulated other comprehensive income (loss) to net income |
||
|
Gain (loss) on derivative financial instruments:
|
|
|
|
||
|
Aluminum future contracts, before taxes
|
$
|
(160
|
)
|
|
Cost of sales
|
|
Foreign currency forward contracts, before taxes
|
15
|
|
|
Cost of sales
|
|
|
Total, before taxes
|
(145
|
)
|
|
|
|
|
Income tax expense (benefit)
|
(53
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(92
|
)
|
|
|
|
Amortization of pension and other post-retirement benefits:
|
|
|
|
||
|
Actuarial gain (loss) and prior service costs, before taxes
|
$
|
(3,086
|
)
|
|
(a)
|
|
Income tax expense (benefit)
|
(1,120
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(1,966
|
)
|
|
|
|
(a)
|
This component of accumulated other comprehensive income (loss) is included in the computation of net periodic pension cost (see Note 8 for additional detail).
|
|
(In Thousands)
|
Amount
reclassified from other comprehensive income (loss) |
|
Location of gain
(loss) reclassified from accumulated other comprehensive income (loss) to net income |
||
|
Gain (loss) on derivative financial instruments:
|
|
|
|
||
|
Aluminum future contracts, before taxes
|
$
|
(1,669
|
)
|
|
Cost of sales
|
|
Foreign currency forward contracts, before taxes
|
46
|
|
|
Cost of sales
|
|
|
Total, before taxes
|
(1,623
|
)
|
|
|
|
|
Income tax expense (benefit)
|
(600
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(1,023
|
)
|
|
|
|
Amortization of pension and other post-retirement benefits:
|
|
|
|
||
|
Actuarial gain (loss) and prior service costs, before taxes
|
$
|
(9,759
|
)
|
|
(a)
|
|
Income tax expense (benefit)
|
(3,186
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(6,573
|
)
|
|
|
|
(a)
|
This component of accumulated other comprehensive income (loss) is included in the computation of net periodic pension cost (see Note 8 for additional detail).
|
|
(In Thousands)
|
Amount
reclassified from other comprehensive income (loss) |
|
Location of gain
(loss) reclassified from accumulated other comprehensive income (loss) to net income (loss) |
||
|
Gain (loss) on derivative financial instruments:
|
|
|
|
||
|
Aluminum future contracts, before taxes
|
$
|
(1,338
|
)
|
|
Cost of sales
|
|
Foreign currency forward contracts, before taxes
|
15
|
|
|
Cost of sales
|
|
|
Total, before taxes
|
(1,323
|
)
|
|
|
|
|
Income tax expense (benefit)
|
(498
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(825
|
)
|
|
|
|
Amortization of pension and other post-retirement benefits:
|
|
|
|
||
|
Actuarial gain (loss) and prior service costs, before taxes
|
$
|
(4,028
|
)
|
|
(a)
|
|
Income tax expense (benefit)
|
(1,478
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(2,550
|
)
|
|
|
|
(a)
|
This component of accumulated other comprehensive income (loss) is included in the computation of net periodic pension cost (see Note 8 for additional detail).
|
|
(In Thousands)
|
Amount
reclassified from other comprehensive income (loss) |
|
Location of gain
(loss) reclassified from accumulated other comprehensive income (loss) to net income (loss) |
||
|
Gain (loss) on derivative financial instruments:
|
|
|
|
||
|
Aluminum future contracts, before taxes
|
$
|
(1,867
|
)
|
|
Cost of sales
|
|
Foreign currency forward contracts, before taxes
|
46
|
|
|
Cost of sales
|
|
|
Total, before taxes
|
(1,821
|
)
|
|
|
|
|
Income tax expense (benefit)
|
(687
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(1,134
|
)
|
|
|
|
Amortization of pension and other post-retirement benefits:
|
|
|
|
||
|
Actuarial gain (loss) and prior service costs, before taxes
|
$
|
(11,997
|
)
|
|
(a)
|
|
Income tax expense (benefit)
|
(4,402
|
)
|
|
Income taxes
|
|
|
Total, net of tax
|
$
|
(7,595
|
)
|
|
|
|
(a)
|
This component of accumulated other comprehensive income (loss) is included in the computation of net periodic pension cost (see Note 8 for additional detail).
|
|
6.
|
In August 2007 and December 2008, the Company made an aggregate investment of
$7.5 million
in kaléo, a privately held specialty pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. The mission of kaléo is to provide products that empower patients to confidently take control of their medical conditions. Tredegar’s ownership interest on a fully diluted basis was approximately
19%
at
September 30, 2016
, and the investment is accounted for under the fair value method. At the time of the initial investment, the Company elected the fair value option over the equity method of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests.
|
|
(In Thousands)
|
September 30, 2016
|
|
December 31, 2015
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||||||
|
Assets:
|
|
|
|
|
Liabilities & Equity:
|
|
|
|
||||||||
|
Cash & short-term investments
|
$
|
111,305
|
|
|
$
|
91,844
|
|
|
|
|
|
|
||||
|
Restricted cash
|
30
|
|
|
8,182
|
|
|
|
|
|
|
||||||
|
Other current assets
|
16,361
|
|
|
9,070
|
|
|
Current liabilities
|
$
|
54,434
|
|
|
$
|
10,261
|
|
||
|
Property & equipment
|
14,072
|
|
|
8,453
|
|
|
Long term debt, net
|
143,212
|
|
|
142,696
|
|
||||
|
Patents
|
2,865
|
|
|
2,811
|
|
|
Other noncurrent liabilities
|
767
|
|
|
552
|
|
||||
|
Other long-term assets
|
93
|
|
|
92
|
|
|
Equity
|
(53,687
|
)
|
|
(33,057
|
)
|
||||
|
Total assets
|
$
|
144,726
|
|
|
$
|
120,452
|
|
|
Total liabilities & equity
|
$
|
144,726
|
|
|
$
|
120,452
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Revenues & Expenses:
|
|
|
|
|
|
|
|
||||||||
|
Revenues, net
|
$
|
17,377
|
|
|
$
|
28,084
|
|
|
$
|
29,347
|
|
|
$
|
43,002
|
|
|
Cost of goods sold
|
(2,956
|
)
|
|
(3,438
|
)
|
|
(10,564
|
)
|
|
(8,575
|
)
|
||||
|
Expenses and other, net (a)
|
(22,216
|
)
|
|
(17,337
|
)
|
|
(39,815
|
)
|
|
(45,727
|
)
|
||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
(8
|
)
|
|
(4
|
)
|
||||
|
Net income (loss)
|
$
|
(7,795
|
)
|
|
$
|
7,309
|
|
|
$
|
(21,040
|
)
|
|
$
|
(11,304
|
)
|
|
(a) “Expenses and other, net” includes selling, general and administrative expense, research and development expense, gain on contract termination, interest expense and other income (expense), net. Excluding the gain on contract termination, “Expenses and other, net” would have been a net deduction of $22.2 million and $57.9 million in the third quarter and first nine months of 2016, respectively.
|
|||||||||||||||
|
7.
|
Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions and currency exchange rate exposures that exist as part of ongoing PE Films and Flexible Packaging Films business operations. These derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the consolidated balance sheet at fair value. The fair value of derivative instruments recorded on the consolidated balance sheets are based upon Level 2 inputs. If individual derivative
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||||||
|
(In Thousands)
|
Balance Sheet
Account
|
|
Fair
Value
|
|
Balance Sheet
Account
|
|
Fair
Value
|
||||
|
Derivatives Designated as Hedging Instruments
|
|
|
|
|
|
|
|
||||
|
Asset derivatives:
Aluminum futures contracts |
Accrued expenses
|
|
$
|
59
|
|
|
Accrued expenses
|
|
$
|
44
|
|
|
Liability derivatives:
Aluminum futures contracts |
Accrued expenses
|
|
$
|
(236
|
)
|
|
Accrued expenses
|
|
$
|
(1,797
|
)
|
|
|
|
|
|
|
|
|
|
||||
|
Derivatives Not Designated as Hedging Instruments
|
|
|
|
|
|
|
|||||
|
Asset derivatives:
Aluminum futures contracts |
Accrued expenses
|
|
$
|
—
|
|
|
Accrued expenses
|
|
$
|
—
|
|
|
Liability derivatives:
Aluminum futures contracts |
Accrued expenses
|
|
$
|
—
|
|
|
Accrued expenses
|
|
$
|
—
|
|
|
Net asset (liability)
|
|
|
$
|
(177
|
)
|
|
|
|
$
|
(1,753
|
)
|
|
(In Thousands)
|
Cash Flow Derivative Hedges
|
||||||||||||||
|
|
Aluminum Futures Contracts
|
|
Foreign Currency Forwards
|
||||||||||||
|
|
Three Months Ended September 30,
|
||||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Amount of pre-tax gain (loss) recognized in other comprehensive income (loss)
|
$
|
(230
|
)
|
|
$
|
(1,570
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (loss) (effective portion)
|
Cost of
sales |
|
|
Cost of
sales |
|
|
Cost of
sales |
|
|
Cost of
sales |
|
||||
|
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (loss) (effective portion)
|
$
|
(160
|
)
|
|
$
|
(1,338
|
)
|
|
$
|
15
|
|
|
$
|
15
|
|
|
|
Aluminum Futures Contracts
|
|
Foreign Currency Forwards
|
||||||||||||
|
|
Nine Months Ended September 30,
|
||||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Amount of pre-tax gain (loss) recognized in other comprehensive income (loss)
|
$
|
(93
|
)
|
|
$
|
(4,699
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (loss) (effective portion)
|
Cost of
sales |
|
|
Cost of
sales |
|
|
Cost of
sales |
|
|
Cost of
sales |
|
||||
|
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (loss) (effective portion)
|
$
|
(1,669
|
)
|
|
$
|
(1,867
|
)
|
|
$
|
46
|
|
|
$
|
46
|
|
|
8.
|
The Company sponsors noncontributory defined benefit (pension) plans covering most employees. The plans for salaried and hourly employees currently in effect are based on a formula using the participant’s years of service and compensation or using the participant’s years of service and a dollar amount. The plan was closed to new participants in 2006 and pay for active plan participants was frozen as of December 31, 2007. With the exception of plan participants at one of Tredegar’s U.S. manufacturing facilities, the plan no longer accrues benefits associated with crediting employees for service, thereby freezing future benefits under the plan.
|
|
|
Pension Benefits
|
|
Other Post-Retirement Benefits
|
||||||||||||
|
|
Three Months Ended September 30,
|
|
Three Months Ended September 30,
|
||||||||||||
|
(In Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Service cost
|
$
|
54
|
|
|
$
|
110
|
|
|
$
|
8
|
|
|
$
|
9
|
|
|
Interest cost
|
3,263
|
|
|
3,288
|
|
|
67
|
|
|
77
|
|
||||
|
Expected return on plan assets
|
(4,070
|
)
|
|
(4,413
|
)
|
|
—
|
|
|
—
|
|
||||
|
Amortization of prior service costs, gains or losses and net transition asset
|
3,135
|
|
|
4,094
|
|
|
(49
|
)
|
|
(65
|
)
|
||||
|
Net periodic benefit cost
|
$
|
2,382
|
|
|
$
|
3,079
|
|
|
$
|
26
|
|
|
$
|
21
|
|
|
|
Pension Benefits
|
|
Other Post-Retirement Benefits
|
||||||||||||
|
|
Nine Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Service cost
|
$
|
178
|
|
|
$
|
398
|
|
|
$
|
29
|
|
|
$
|
33
|
|
|
Interest cost
|
9,993
|
|
|
9,913
|
|
|
236
|
|
|
244
|
|
||||
|
Expected return on plan assets
|
(12,027
|
)
|
|
(13,227
|
)
|
|
—
|
|
|
—
|
|
||||
|
Amortization of prior service costs, (gains) losses and net transition asset
|
9,903
|
|
|
12,142
|
|
|
(144
|
)
|
|
(145
|
)
|
||||
|
Net periodic benefit cost
|
$
|
8,047
|
|
|
$
|
9,226
|
|
|
$
|
121
|
|
|
$
|
132
|
|
|
9.
|
The Company’s business segments are PE Films, Flexible Packaging and Aluminum Extrusions. Information by business segment is reported below. There are no accounting transactions between segments and no allocations to segments. Net sales (sales less freight) and operating profit from ongoing operations are the measures of sales and operating profit used by the chief operating decision maker for purposes of assessing performance.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
(In Thousands)
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
Net Sales
|
|
|
|
|
|
|
|
||||||||
|
PE Films
|
$
|
82,179
|
|
|
$
|
93,943
|
|
|
$
|
251,473
|
|
|
$
|
292,259
|
|
|
Flexible Packaging Films
|
27,303
|
|
|
27,155
|
|
|
80,888
|
|
|
77,339
|
|
||||
|
Aluminum Extrusions
|
91,067
|
|
|
94,812
|
|
|
269,987
|
|
|
286,660
|
|
||||
|
Total net sales
|
200,549
|
|
|
215,910
|
|
|
602,348
|
|
|
656,258
|
|
||||
|
Add back freight
|
7,153
|
|
|
7,862
|
|
|
21,221
|
|
|
22,930
|
|
||||
|
Sales as shown in the Consolidated Statements of Income
|
$
|
207,702
|
|
|
$
|
223,772
|
|
|
$
|
623,569
|
|
|
$
|
679,188
|
|
|
Operating Profit
|
|
|
|
|
|
|
|
||||||||
|
PE Films:
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations
|
$
|
9,011
|
|
|
$
|
9,745
|
|
|
$
|
23,564
|
|
|
$
|
35,849
|
|
|
Plant shutdowns, asset impairments, restructurings and other
|
(1,187
|
)
|
|
(2,044
|
)
|
|
(3,678
|
)
|
|
(2,051
|
)
|
||||
|
Flexible Packaging Films:
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations
|
93
|
|
|
4,102
|
|
|
1,184
|
|
|
1,793
|
|
||||
|
Plant shutdowns, asset impairments, restructurings and other
|
—
|
|
|
—
|
|
|
—
|
|
|
(185
|
)
|
||||
|
Goodwill impairment charge
|
—
|
|
|
(44,465
|
)
|
|
—
|
|
|
(44,465
|
)
|
||||
|
Aluminum Extrusions:
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations
|
9,427
|
|
|
7,272
|
|
|
27,786
|
|
|
20,863
|
|
||||
|
Plant shutdowns, asset impairments, restructurings and other
|
1,405
|
|
|
(331
|
)
|
|
840
|
|
|
(364
|
)
|
||||
|
Total
|
18,749
|
|
|
(25,721
|
)
|
|
49,696
|
|
|
11,440
|
|
||||
|
Interest income
|
70
|
|
|
76
|
|
|
158
|
|
|
247
|
|
||||
|
Interest expense
|
886
|
|
|
901
|
|
|
2,918
|
|
|
2,679
|
|
||||
|
Loss on investment accounted for under fair value method
|
(1,300
|
)
|
|
—
|
|
|
(200
|
)
|
|
—
|
|
||||
|
Stock option-based compensation costs
|
31
|
|
|
73
|
|
|
24
|
|
|
571
|
|
||||
|
Corporate expenses, net
|
7,223
|
|
|
6,722
|
|
|
22,110
|
|
|
25,632
|
|
||||
|
Income (loss) before income taxes
|
9,379
|
|
|
(33,341
|
)
|
|
24,602
|
|
|
(17,195
|
)
|
||||
|
Income taxes (benefit)
|
(2,669
|
)
|
|
3,382
|
|
|
1,864
|
|
|
9,064
|
|
||||
|
Net income (loss)
|
$
|
12,048
|
|
|
$
|
(36,723
|
)
|
|
$
|
22,738
|
|
|
$
|
(26,259
|
)
|
|
(In Thousands)
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
PE Films
|
$
|
287,516
|
|
|
$
|
270,236
|
|
|
Flexible Packaging Films
|
157,069
|
|
|
146,253
|
|
||
|
Aluminum Extrusions
|
149,187
|
|
|
136,935
|
|
||
|
Subtotal
|
593,772
|
|
|
553,424
|
|
||
|
General corporate
|
33,642
|
|
|
25,680
|
|
||
|
Cash and cash equivalents
|
28,356
|
|
|
44,156
|
|
||
|
Total
|
$
|
655,770
|
|
|
$
|
623,260
|
|
|
10.
|
Tredegar recorded tax expense of
$1.9 million
on pre-tax net income of
$24.6 million
in the first
nine months
of
2016
, which included the recognition of a
$5.7 million
tax benefit related to the repatriation of cash from operations in Brazil. For the first nine months of 2015, Tredegar recorded tax expense of
$9.1 million
on pre-tax net losses from continuing operations of
$17.2 million
due to a non-deductible goodwill impairment charge of
$44.5 million
. Therefore, the effective tax rate in the first
nine months
of
2016
was
7.6%
, compared to
(52.7)%
in the first
nine months
of
2015
. The significant differences between the U.S. federal statutory rate and the effective income tax rate for the
nine months
ended
September 30, 2016
and
2015
are as follows:
|
|
|
Percent of Income
Before Income Taxes
|
||||
|
Nine Months Ended September 30,
|
2016
|
|
2015
|
||
|
Income tax expense at federal statutory rate
|
35.0
|
|
|
35.0
|
|
|
Non-deductible expenses
|
1.6
|
|
|
(1.7
|
)
|
|
Income tax contingency accruals and tax settlements
|
1.3
|
|
|
(2.8
|
)
|
|
Foreign rate differences
|
1.1
|
|
|
2.8
|
|
|
State taxes, net of federal income tax benefit
|
0.7
|
|
|
(2.4
|
)
|
|
Valuation allowance for foreign operating loss carry-forwards
|
0.3
|
|
|
(1.0
|
)
|
|
Foreign investment write-up
|
0.1
|
|
|
—
|
|
|
Valuation allowance for capital loss carry-forwards
|
(0.4
|
)
|
|
1.8
|
|
|
Unremitted earnings from foreign operations
|
(1.1
|
)
|
|
(2.0
|
)
|
|
Changes in estimates related to prior year tax provision
|
(1.6
|
)
|
|
2.9
|
|
|
Research and development tax credit
|
(1.8
|
)
|
|
—
|
|
|
Domestic production activities deduction
|
(3.8
|
)
|
|
5.1
|
|
|
Remitted earnings from foreign operations
|
(23.8
|
)
|
|
—
|
|
|
Goodwill impairment charge
|
—
|
|
|
(90.5
|
)
|
|
Other
|
—
|
|
|
0.1
|
|
|
Effective income tax rate
|
7.6
|
|
|
(52.7
|
)
|
|
11.
|
On March 1, 2016, Tredegar entered into a
$400 million
five
-year, secured revolving credit facility (“Credit Agreement”), with an option to increase that amount by
$50 million
. The Credit Agreement replaced the Company’s previous
$350 million
five-year, unsecured revolving credit facility that was due to expire on April 17, 2017. In connection with the refinancing, the Company borrowed
$107 million
under the Credit Agreement, which was used, together with available cash on hand, to repay all indebtedness under the previous revolving credit facility.
|
|
Pricing Under Credit Revolving Agreement (Basis Points)
|
||||||
|
Indebtedness-to-Adjusted EBITDA Ratio
|
Credit Spread
Over LIBOR
|
|
Commitment
Fee
|
|||
|
> 3.5x but <= 4.0x
|
250
|
|
|
45
|
|
|
|
> 3.0x but <= 3.5x
|
225
|
|
|
40
|
|
|
|
> 2.0x but <= 3.0x
|
200
|
|
|
35
|
|
|
|
> 1.0x but <= 2.0x
|
175
|
|
|
30
|
|
|
|
<= 1.0x
|
150
|
|
|
25
|
|
|
|
•
|
Maximum indebtedness-to-adjusted EBITDA (“Leverage Ratio:) of
4.00x
;
|
|
•
|
Minimum adjusted EBIT-to-interest expense of
2.50x
; and
|
|
•
|
Maximum aggregate distributions to shareholders over the term of the Credit Agreement of
$100,000
plus, beginning with the fiscal quarter ended March 31, 2016,
50%
of net income and, at a Leverage Ratio of equal to or greater than
3.00
x, a limitation on such payments for the succeeding quarter at the greater of (i)
$4 million
and (ii)
50%
of consolidated net income for the most recent fiscal quarter, and, at a Leverage Ratio of equal to or greater than
3.50
x, the prevention of such payments for the succeeding quarter unless the fixed charge coverage ratio is equal to or greater than
1.20
x.
|
|
12.
|
In 2011, Tredegar was notified by U.S. Customs and Border Protection (“U.S. Customs”) that certain film products exported by Terphane to the U.S. since November 6, 2008 could be subject to duties associated with an antidumping duty order on imported PET films from Brazil. The Company contested the applicability of these antidumping duties to the films exported by Terphane, and it filed a request with the U.S. Department of Commerce (“Commerce”) for clarification about whether the film products at issue are within the scope of the antidumping duty order. On January 8, 2013, Commerce issued a scope ruling confirming that the films are not subject to the order, provided that Terphane can establish to the satisfaction of U.S. Customs that the performance enhancing layer on those films is greater than
0.00001
inches thick. The films at issue are manufactured to specifications that exceed that threshold. On February 6, 2013, certain U.S. producers of PET film filed a summons with the U.S. Court of International Trade to appeal the scope ruling from Commerce. If U.S. Customs ultimately were to require the collection of anti-dumping duties because Commerce’s scope ruling was overturned on appeal, or otherwise, indemnifications for related liabilities are specifically provided for under the purchase agreement pursuant to which the Company acquired Terphane. In December 2014, the U.S. International Trade Commission voted to revoke the anti-dumping duty order on imported PET films from Brazil. The revocation, as a result of the vote by the U.S. International Trade Commission, was effective as of November 2013. On February 20, 2015, certain U.S. producers of PET films filed a summons with the U.S. Court of International Trade to appeal the determination by the U.S. International Trade Commission. The Court granted a motion by the plaintiffs to stay the appeal of the revocation decision pending the resolution of the scope appeal. A decision by the Court in the scope appeal remains pending.
|
|
13.
|
In May 2014, the Financial Accounting Standards Board (“FASB”) and International Accounting Standards Board (“IASB”) issued their converged standard on revenue recognition. The revised revenue standard contains principles that an entity will apply to direct the measurement of revenue and timing of when it is recognized. The core principle of the guidance is that the recognition of revenue should depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods and services. To achieve that core principle, an entity will utilize a principle-based five-step approach model. The converged standard also includes more robust disclosure requirements which will require entities to provide sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. In March 2016, amended guidance was issued regarding clarifying the implementation guidance on principal versus agent considerations and in April 2016, clarifying guidance was issued relating to identifying performance obligations and licensing implementation. The effective date of this revised standard is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early application is permitted as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that annual reporting period. The converged standard can be adopted either retrospectively or through the use of a practical expedient. The Company is currently assessing the impact of this standard.
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
|
Three Months Ended
|
|
Favorable/
(Unfavorable) % Change |
|
Nine Months Ended
|
|
Favorable/
(Unfavorable) % Change |
||||||||||||||
|
(In Thousands, Except Percentages)
|
September 30,
|
|
September 30,
|
|
|||||||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||||||||||||
|
Sales volume (lbs)
|
33,754
|
|
|
40,023
|
|
|
(15.7
|
)%
|
|
106,214
|
|
|
121,866
|
|
|
(12.8
|
)%
|
||||
|
Net sales
|
$
|
82,179
|
|
|
$
|
93,943
|
|
|
(12.5
|
)%
|
|
$
|
251,473
|
|
|
$
|
292,259
|
|
|
(14.0
|
)%
|
|
Operating profit from ongoing operations
|
$
|
9,011
|
|
|
$
|
9,745
|
|
|
(7.5
|
)%
|
|
$
|
23,564
|
|
|
$
|
35,849
|
|
|
(34.3
|
)%
|
|
•
|
The wind down of volume related to lost business in personal care materials with PE Films’ largest customer ($6.3 million) and other personal care customers ($1.2 million) (see discussion below);
|
|
•
|
Lower volume in personal care materials primarily due to the timing of product transitions ($3.8 million);
|
|
•
|
An increase in surface protection films revenue ($1.8 million) primarily due to an improved sales mix; and
|
|
•
|
Lower volume of low margin overwrap films ($2.3 million) primarily due to the loss of business with a large customer.
|
|
|
Three Months Ended September 30,
|
|||||
|
(In Thousands)
|
2016
|
2015
|
||||
|
Operating profit from ongoing operations, as reported
|
$
|
9,011
|
|
$
|
9,745
|
|
|
Contribution to operating profit from ongoing operations associated with known product transitions & other losses before restructurings & fixed costs reduction
|
236
|
|
3,023
|
|
||
|
Operating profit from ongoing operations net of the impact of known business that will be fully eliminated in future periods
|
8,775
|
|
6,722
|
|
||
|
Estimated future benefit of North American facility consolidation
|
1,300
|
|
1,300
|
|
||
|
Pro forma estimated operating profit from ongoing operations
|
$
|
10,075
|
|
$
|
8,022
|
|
|
•
|
Higher contribution to profits from surface protection films ($1.2 million), primarily due to a favorable sales mix;
|
|
•
|
Lower contribution to profits in personal care materials primarily due to sales declines resulting from the timing of product transitions ($0.4 million);
|
|
•
|
Higher contribution to profits from other products in PE Films ($1.0 million); and
|
|
•
|
Higher research and development (“R&D”) expenses to support new product opportunities ($0.7 million), offset by lower general, sales and administrative expenses and productivity improvements ($0.9 million).
|
|
•
|
The loss of business with PE Films’ largest customer related to various products in personal care materials ($17.1 million) and other personal care materials customers ($6.4 million);
|
|
•
|
Lower volume in personal care materials primarily due to the timing of product transitions ($8.0 million);
|
|
•
|
A decline in volume in surface protection films ($3.5 million) that is believed to be the result of lower consumer demand for products with flat panel display screens in the first half of 2016; and
|
|
•
|
Lower volume of low margin overwrap films ($7.1 million) primarily due to the loss of business with a large customer, partially offset by sales growth in other areas ($1.3 million).
|
|
|
Nine Months Ended September 30,
|
|||||
|
(In Thousands)
|
2016
|
2015
|
||||
|
Operating profit from ongoing operations, as reported
|
$
|
23,564
|
|
$
|
35,849
|
|
|
Contribution to operating profit from ongoing operations associated with known product transitions & other losses before restructurings & fixed costs reduction
|
2,843
|
|
10,638
|
|
||
|
Operating profit from ongoing operations net of the impact of known business that will be fully eliminated in future periods
|
20,721
|
|
25,211
|
|
||
|
Estimated future benefit of North American facility consolidation
|
3,900
|
|
3,900
|
|
||
|
Pro forma estimated operating profit from ongoing operations
|
$
|
24,621
|
|
$
|
29,111
|
|
|
•
|
Lower contribution to profits from surface protection films ($2.9 million) primarily due to lower volume and unfavorable sales mix changes;
|
|
•
|
Lower contribution to profits in personal care materials primarily due to volume declines resulting from the timing of product transitions ($3.0 million);
|
|
•
|
Higher contribution to profits from other products in PE Films ($0.5 million); and
|
|
•
|
Higher research and development expenses to support new product opportunities ($2.6 million), offset by lower general, sales and administrative expenses ($2.0 million) and lower depreciation ($1.2 million).
|
|
•
|
Cash outlays associated with previously discussed exit and disposal expenses of approximately
$5 million
, including additional operating expenses of approximately
$1 million
associated with customer product qualifications on upgraded and transferred production lines;
|
|
•
|
Capital expenditures associated with equipment upgrades at other PE Films manufacturing facilities in the U.S. of approximately
$11 million
; and
|
|
•
|
Cash incentives of approximately
$1 million
in connection with meeting safety and quality standards while production ramps down at the Lake Zurich manufacturing facility.
|
|
|
Three Months Ended
|
|
Favorable/
(Unfavorable) % Change |
|
Nine Months Ended
|
|
Favorable/
(Unfavorable) % Change |
||||||||||||||
|
(In Thousands, Except Percentages)
|
September 30,
|
|
September 30,
|
|
|||||||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||||||||||||
|
Sales volume (lbs)
|
23,204
|
|
|
22,495
|
|
|
3.2
|
%
|
|
66,222
|
|
|
59,968
|
|
|
10.4
|
%
|
||||
|
Net sales
|
$
|
27,303
|
|
|
$
|
27,155
|
|
|
0.5
|
%
|
|
$
|
80,888
|
|
|
$
|
77,339
|
|
|
4.6
|
%
|
|
Operating profit from ongoing operations
|
$
|
93
|
|
|
$
|
4,102
|
|
|
(97.7
|
)%
|
|
$
|
1,184
|
|
|
$
|
1,793
|
|
|
(34.0
|
)%
|
|
•
|
Net refunds of $2.0 million in the third quarter of 2015 (none in 2016) received as a result of the reinstatement by the U.S. of the Generalized System of Preferences (GSP) program for allowing duty-free shipment of Terphane’s products to the U.S.; and
|
|
•
|
Foreign currency transaction gains of $0.1 million in the third quarter of 2016 versus $2.2 million in the third quarter of 2015, associated with U.S. dollar denominated export sales in Brazil.
|
|
•
|
Foreign currency transaction losses of $3.2 million in the first nine months of 2016 versus foreign currency transaction gains of $3.6 million in the first nine months of 2015, associated with U.S. dollar denominated export sales in Brazil;
|
|
•
|
Higher volume ($2.7 million) and operating efficiencies ($3.2 million);
|
|
•
|
Net refunds of $1.5 million in the first nine months of 2015 received as a result of the reinstatement of the GSP program (none in 2016);
|
|
•
|
The estimated lag in the pass through of lower raw material costs of $1.2 million in the first nine months of 2016 versus $0.1 million in the first nine months of 2015; and
|
|
•
|
Lower depreciation and amortization costs ($0.4 million) and other costs and expenses ($0.3 million).
|
|
|
Three Months Ended
|
|
Favorable/
(Unfavorable) % Change |
|
Nine Months Ended
|
|
Favorable/
(Unfavorable) % Change |
||||||||||||||
|
(In Thousands, Except Percentages)
|
September 30,
|
|
September 30,
|
|
|||||||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||||||||||||
|
Sales volume (lbs)
|
43,549
|
|
|
44,811
|
|
|
(2.8
|
)%
|
|
129,872
|
|
|
127,184
|
|
|
2.1
|
%
|
||||
|
Net sales
|
$
|
91,067
|
|
|
$
|
94,812
|
|
|
(3.9
|
)%
|
|
$
|
269,987
|
|
|
$
|
286,660
|
|
|
(5.8
|
)%
|
|
Operating profit from ongoing operations
|
$
|
9,427
|
|
|
$
|
7,272
|
|
|
29.6
|
%
|
|
$
|
27,786
|
|
|
$
|
20,863
|
|
|
33.2
|
%
|
|
|
Three Months Ended September 30,
|
||||||
|
(In Millions)
|
2016
|
|
2015
|
||||
|
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
|
|
|
|
||||
|
Average outstanding debt balance
|
$
|
99.2
|
|
|
$
|
137.2
|
|
|
Average interest rate
|
2.3
|
%
|
|
2.0
|
%
|
||
|
Fixed-rate and other debt:
|
|
|
|
||||
|
Average outstanding debt balance
|
$
|
—
|
|
|
$
|
—
|
|
|
Average interest rate
|
n/a
|
|
|
n/a
|
|
||
|
Total debt:
|
|
|
|
||||
|
Average outstanding debt balance
|
$
|
99.2
|
|
|
$
|
137.2
|
|
|
Average interest rate
|
2.3
|
%
|
|
2.0
|
%
|
||
|
|
Nine Months Ended September 30,
|
||||||
|
(In Millions)
|
2016
|
|
2015
|
||||
|
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
|
|
|
|
||||
|
Average outstanding debt balance
|
$
|
104.8
|
|
|
$
|
139.5
|
|
|
Average interest rate
|
2.3
|
%
|
|
2.0
|
%
|
||
|
Fixed-rate and other debt:
|
|
|
|
||||
|
Average outstanding debt balance
|
$
|
—
|
|
|
$
|
—
|
|
|
Average interest rate
|
n/a
|
|
|
n/a
|
|
||
|
Total debt:
|
|
|
|
||||
|
Average outstanding debt balance
|
$
|
104.8
|
|
|
$
|
139.5
|
|
|
Average interest rate
|
2.3
|
%
|
|
2.0
|
%
|
||
|
•
|
Accounts and other receivables increased
$10.2 million
(
10.8%
).
|
|
•
|
Accounts receivable in PE Films increased by $3.7 million primarily due to the timing of cash receipts. DSO (represents trailing 12 months net sales divided by a rolling 12-month average of accounts and other receivables balances) was approximately 44.2 days for the 12 months ended
September 30, 2016
and 42.7 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Accounts receivable in Flexible Packaging Films decreased by $1.5 million primarily due to lower sales and due to the timing of cash receipts. DSO was approximately 53.7 days for the 12 months ended
September 30, 2016
and 68.9 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Accounts receivable in Aluminum Extrusions increased by $7.9 million primarily due to the recording of an insurance receivable of $2.5 million related to the Bonnell cast house explosion and the timing of cash receipts. DSO was approximately 42.9 days for the 12 months ended
September 30, 2016
and 45.1 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Inventories increased
$7.9 million
(
12.2%
).
|
|
•
|
Inventories in PE Films increased by approximately $4.8 million primarily due to the timing of raw material purchases. DIO (represents trailing 12 months costs of goods sold calculated on a first-in, first-out basis divided by a rolling 12-month average of inventory balances calculated on the first-in, first-out basis) was approximately 51.0 days for the 12 months ended
September 30, 2016
and 48.3 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Inventories in Flexible Packaging Films increased by approximately $0.4 million primarily due to the timing of raw material purchases. DIO was approximately 77.6 days for the 12 months ended
September 30, 2016
and 81.6 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Inventories in Aluminum Extrusions increased by $2.6 million due to third party purchases of raw materials due to the explosion at the Bonnell cast house and the timing of purchases. DIO was approximately 27.0 days for the 12 months ended
September 30, 2016
and 29.8 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Net property, plant and equipment increased
$25.5 million
(
11.0%
) primarily due to capital expenditures of
$30.9 million
and a change in the value of the U.S. Dollar relative to foreign currencies ($15.5 million increase), partially offset by depreciation expenses of
$21.0 million
.
|
|
•
|
Accounts payable increased
$3.9 million
(
4.7%
).
|
|
•
|
Accounts payable in PE Films decreased $1.8 million due to the normal volatility associated with the timing of payments. DPO (represents trailing 12 months costs of goods sold calculated on a first-in, first-out basis divided by a rolling 12-month average of accounts payable balances) was approximately 39.4 days for the 12 months ended
September 30, 2016
and 39.0 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Accounts payable in Flexible Packaging Films increased $2.4 million due to an effort implemented to increase payment terms with suppliers. DPO was approximately 36.9 days for the 12 months ended
September 30, 2016
and 34.2 days for the 12 months ended
December 31, 2015
.
|
|
•
|
Accounts payable in Aluminum Extrusions increased by $4.5 million primarily due to the normal volatility associated with the timing of inventory purchases. DPO was approximately 45.1 days for the 12 months ended
September 30, 2016
and 48.0 days for the 12 months ended
December 31, 2015
.
|
|
Net Capitalization and Indebtedness as of September 30, 2016
|
|||
|
(In Thousands)
|
|||
|
Net capitalization:
|
|
||
|
Cash and cash equivalents
|
$
|
28,356
|
|
|
Debt:
|
|
||
|
$400 million revolving credit agreement maturing March 1, 2021
|
91,750
|
|
|
|
Other debt
|
—
|
|
|
|
Total debt
|
91,750
|
|
|
|
Debt, net of cash and cash equivalents
|
63,394
|
|
|
|
Shareholders’ equity
|
317,918
|
|
|
|
Net capitalization
|
$
|
381,312
|
|
|
Indebtedness as defined in revolving credit agreement:
|
|
||
|
Total debt
|
$
|
91,750
|
|
|
Face value of letters of credit
|
2,685
|
|
|
|
Other
|
533
|
|
|
|
Indebtedness
|
$
|
94,968
|
|
|
Pricing Under Revolving Credit Agreement (Basis Points)
|
|||||
|
Indebtedness-to-Adjusted EBITDA Ratio
|
Credit Spread
Over LIBOR
|
|
Commitment
Fee
|
||
|
> 3.5x but <= 4.0x
|
250
|
|
|
45
|
|
|
> 3.0x but <= 3.5x
|
225
|
|
|
40
|
|
|
> 2.0x but <= 3.0x
|
200
|
|
|
35
|
|
|
> 1.0x but <= 2.0x
|
175
|
|
|
30
|
|
|
<= 1.0x
|
150
|
|
|
25
|
|
|
Computations of Adjusted EBITDA, Adjusted EBIT, Leverage Ratio and Interest Coverage Ratio as Defined in the Revolving Credit Agreement Along with Related Most Restrictive Covenants as of and for the Twelve Months Ended September 30, 2016 (In Thousands)
|
|||
|
Computations of adjusted EBITDA and adjusted EBIT as defined in revolving credit agreement for the twelve months ended September 30, 2016:
|
|||
|
Net income (loss)
|
$
|
16,863
|
|
|
Plus:
|
|
||
|
After-tax losses related to discontinued operations
|
—
|
|
|
|
Total income tax expense for continuing operations
|
1,728
|
|
|
|
Interest expense
|
3,741
|
|
|
|
Depreciation and amortization expense for continuing operations
|
31,907
|
|
|
|
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $7,518)
|
8,347
|
|
|
|
Charges related to stock option grants and awards accounted for under the fair value-based method
|
—
|
|
|
|
Losses related to the application of the equity method of accounting
|
—
|
|
|
|
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting
|
20,700
|
|
|
|
Minus:
|
|
||
|
After-tax income related to discontinued operations
|
—
|
|
|
|
Total income tax benefits for continuing operations
|
—
|
|
|
|
Interest income
|
(205
|
)
|
|
|
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings
|
—
|
|
|
|
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method
|
(64
|
)
|
|
|
Income related to the application of the equity method of accounting
|
—
|
|
|
|
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting
|
—
|
|
|
|
Plus cash dividends declared on investments accounted for under the equity method of accounting
|
—
|
|
|
|
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions
|
—
|
|
|
|
Adjusted EBITDA as defined in revolving credit agreement
|
83,017
|
|
|
|
Less: Depreciation and amortization expense for continuing operations (including pro forma for acquisitions and asset dispositions)
|
(31,907
|
)
|
|
|
Adjusted EBIT as defined in revolving credit agreement
|
$
|
51,110
|
|
|
Computations of leverage and interest coverage ratios as defined in revolving credit agreement at September 30, 2016:
|
|||
|
Leverage ratio (indebtedness-to-adjusted EBITDA)
|
1.14x
|
|
|
|
Interest coverage ratio (adjusted EBIT-to-interest expense)
|
13.66x
|
|
|
|
Most restrictive covenants as defined in revolving credit agreement:
|
|
||
|
Maximum permitted aggregate amount of dividends that can be paid by Tredegar during the term of the revolving credit agreement ($100,000 plus 50% of net income generated for each quarter beginning January 1, 2016)
|
$
|
111,369
|
|
|
Maximum leverage ratio permitted
|
4.00
|
|
|
|
Minimum interest coverage ratio permitted
|
2.50
|
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In January 2015, IHS reflected a 21 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2014 average rate of $1.09 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2014.
|
|
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
|
|
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
|
|
Source: Quarterly averages computed using daily Midwest average prices provided by Platts.
|
|
Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.
|
|
Percentage of Net Sales from Ongoing
Operations Related to Foreign Markets*
|
|||||||||||
|
|
Nine Months Ended September 30,
|
||||||||||
|
|
2016
|
|
2015
|
||||||||
|
|
Exports
From U.S.
|
|
Foreign
Operations
|
|
Exports
From U.S.
|
|
Foreign
Operations
|
||||
|
Canada
|
6
|
%
|
|
—
|
%
|
|
5
|
%
|
|
—
|
%
|
|
Europe
|
1
|
|
|
10
|
|
|
1
|
|
|
10
|
|
|
Latin America
|
—
|
|
|
11
|
|
|
—
|
|
|
10
|
|
|
Asia
|
9
|
|
|
3
|
|
|
8
|
|
|
3
|
|
|
Total
|
16
|
%
|
|
24
|
%
|
|
14
|
%
|
|
23
|
%
|
|
* The percentages for foreign markets are relative to Tredegar’s total net sales from ongoing operations
|
|||||||||||
|
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.
|
|
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.
|
|
Item 4.
|
Controls and Procedures.
|
|
Item 1A.
|
Risk Factors.
|
|
Item 6.
|
Exhibits.
|
|
Exhibit
Nos.
|
|
|
|
|
|
|
|
31.1
|
|
Certification of John D. Gottwald, President and Chief Executive Officer of Tredegar Corporation, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
31.2
|
|
Certification of D. Andrew Edwards, Vice President and Chief Financial Officer of Tredegar Corporation, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.1
|
|
Certification of John D. Gottwald, President and Chief Executive Officer of Tredegar Corporation, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.2
|
|
Certification of D. Andrew Edwards, Vice President and Chief Financial Officer of Tredegar Corporation, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101
|
|
XBRL Instance Document and Related Items.
|
|
|
|
|
|
Tredegar Corporation
|
|
|
|
|
|
(Registrant)
|
|
|
|
|
||
|
Date:
|
|
November 1, 2016
|
|
/s/ John D. Gottwald
|
|
|
|
|
|
John D. Gottwald
|
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
Date:
|
|
November 1, 2016
|
|
/s/ D. Andrew Edwards
|
|
|
|
|
|
D. Andrew Edwards
|
|
|
|
|
|
Vice President and Chief Financial Officer
|
|
|
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
Date:
|
|
November 1, 2016
|
|
/s/ Frasier W. Brickhouse, II
|
|
|
|
|
|
Frasier W. Brickhouse, II
|
|
|
|
|
|
Corporate Treasurer and Controller
|
|
|
|
|
|
(Principal Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| International Flavors & Fragrances Inc. | IFF |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|